Form 4: IN8BIO Director Jeremy R. Graff Acquires Stock Options

Director Jeremy R. Graff acquired stock options in IN8BIO, INC. on June 12, 2024.

Summary

• On June 12, 2024, Jeremy R. Graff, a director of IN8BIO, INC., acquired stock options to purchase 33,650 shares of common stock at an exercise price of $1.47.
• The options vest in equal monthly installments starting July 12, 2024, with full vesting by the date of the company's next annual meeting of stockholders, contingent on continued service.
• Following the transaction, Graff directly owns 33,650 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The acquisition of options by a director could be seen as a positive sign, but without further context, it's difficult to assess the overall impact.

Positives

• The acquisition of stock options by a director may indicate confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.

Stakeholder Impact

• The acquisition of stock options by a director could be viewed positively by shareholders, as it aligns the director's interests with the company's performance.

Key Dates